Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-009125
Filing Date
2025-02-04
Accepted
2025-02-04 16:21:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm255410d2_defa14a.htm DEFA14A 27422
2 GRAPHIC tm255410d2_defa14aimg001.jpg GRAPHIC 17018
  Complete submission text file 0001104659-25-009125.txt   52057
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40363 | Film No.: 25588548
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)